Please provide your email address to receive an email when new articles are posted on . INDIANAPOLIS — Individuals with mild to moderate presbyopia who were treated with CSF-1 were able to achieve and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ATLANTA — A study of CSF-1 showed an improvement in near ...

On February 26, 2024, the National Institute of Standards and Technology (NIST) released the Cybersecurity Framework version 2.0 (CSF 2.0). CSF 2.0 is a generational update to NIST’s foundational ...

SAN DIEGO -- A low-dose formulation of pilocarpine significantly improved visual acuity in presbyopia without adversely affecting distance vision, results of two randomized trials showed. As compared ...

The phase 3 NEAR-1 and NEAR-2 trials included 613 patients aged 45 to 64 years with presbyopia. Positive results were announced from two phase 3 trials evaluating the efficacy and safety of CSF-1, a ...